A national open-access research registry to improve recruitment to clinical studies

被引:2
作者
Kotting, Piers [1 ,2 ]
Smith, Adam [1 ]
O'Hare, Megan B. [1 ]
Giebel, Clarissa [3 ,4 ]
Mendis, Lakshini [1 ]
Shaw, Clare [5 ]
Shillito, Imogen [5 ]
Rossor, Martin N. [1 ]
机构
[1] UCL Queen Sq Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat Dis, London WC1N 3BG, England
[2] Univ Exeter, Coll Med & Hlth, Exeter, Devon, England
[3] Univ Liverpool, NIHR Appl Res Collaboration, Liverpool, Merseyside, England
[4] Univ Liverpool, Dept Primary Care & Mental Hlth, Liverpool, Merseyside, England
[5] Univ Leeds, NIHR Clin Res Network Coordinating Ctr, Leeds, W Yorkshire, England
关键词
Alzheimer's disease; clinical trial recruitment; consent-for-approach; consent-for-contact; dementia; online registry; public engagement; registries; registry; research participation; research recruitment; ALZHEIMERS-DISEASE; DEMENTIA;
D O I
10.1002/trc2.12221
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction Barriers to recruitment for dementia studies are well documented. As part of the UK government's Dementia 2020 strategy, a nationally consistent system to increase public engagement and participation in research was launched in February 2015. Methods We describe the development of the "Join Dementia Research" registry, including evolution of policy, involvement of people with dementia in co-production, data requirements, governance, technology, and the impact on study recruitment and what factors may have contributed to the services success. Results The UK-wide online, telephone, and postal service has registered 47,071 volunteers, with 33,139 people (67.9% of all volunteers) taking part in 378 studies, with 49,954 total study enrolments. This has taken place across 295 research sites, involved 1522 researchers, and resulted in 134 peer-reviewed publications. Discussion Public registries of individuals interested in research, with user-provided data enabling basic phenotyping, are effective at increasing public engagement with research and removing barriers to study recruitment. Deeper pheno/genotyping could be undertaken to improve matching, but how and when that information is collected will be a key factor.
引用
收藏
页数:8
相关论文
共 25 条
  • [1] [Anonymous], WELLCOME MONITOR 202
  • [2] [Anonymous], 2020, Worst hit: dementia during coronavirus report
  • [3] RECRUITMENT OF BLACK ELDERLY FOR CLINICAL RESEARCH STUDIES OF DEMENTIA - THE CERAD EXPERIENCE
    BALLARD, EL
    NASH, F
    RAIFORD, K
    HARRELL, LE
    [J]. GERONTOLOGIST, 1993, 33 (04) : 561 - 565
  • [4] Recruitment rates in gerontological research: The situation for drug trials in dementia may be worse than previously reported
    Cohen-Mansfield, J
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 (04) : 279 - 282
  • [5] Department of Health and Social Care, 2012, PRIM MIN CHALL DEM D
  • [6] Co-Production and Health System Reform - From Re-Imagining To Re-Making
    Dunston, Roger
    Lee, Alison
    Boud, David
    Brodie, Pat
    Chiarella, Mary
    [J]. AUSTRALIAN JOURNAL OF PUBLIC ADMINISTRATION, 2009, 68 (01) : 39 - 52
  • [7] 2019 Alzheimer's disease facts and figures
    Gaugler, Joseph
    James, Bryan
    Johnson, Tricia
    Marin, Allison
    Weuve, Jennifer
    [J]. ALZHEIMERS & DEMENTIA, 2019, 15 (03) : 321 - 387
  • [8] Facilitating Alzheimer Disease Research Recruitment
    Grill, Joshua D.
    Galvin, James E.
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2014, 28 (01) : 1 - 8
  • [9] Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials
    Grill, Joshua D.
    Karlawish, Jason
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2010, 2 (06)
  • [10] Harrison Dening K ., 2020, DIAGNOSIS DEMENTIA I